Clinical Trials Logo

Skin Diseases clinical trials

View clinical trials related to Skin Diseases.

Filter by:

NCT ID: NCT04733872 Completed - Skin Condition Clinical Trials

Using Vegetable and Berry Products Can Improve Skin Conditions

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Hypothesis: vegetable and berry products for 8 weeks can improve skin condition

NCT ID: NCT04733859 Completed - Skin Condition Clinical Trials

Using Red Djulis Products Can Improve Skin Conditions

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Hypothesis: Using red djulis products can improve skin conditions

NCT ID: NCT04731389 Completed - Acne Clinical Trials

Digital Strategies for Patients With Chronic Dermatosis With Pruritus / Skin Picking Disorder

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Almost 35% of patients treated to dermatosis have some psychiatric disorder. The aim of this study is to evaluate the prevalence and severity of skin picking disorder and other dermatosis, and also test the efficacy of an online-delivered cognitive-behavioral therapy to improve skin picking disorder severity.

NCT ID: NCT04725292 Completed - Skin Diseases Clinical Trials

Rare Benign Lesion of Peins

Start date: January 12, 2021
Phase:
Study type: Observational

PEKMB was first named and described by Lortat-Jacob & Civatte in 1961 and by Bart & Kopf later. This rare condition is mostly reported in elderly males. The keratotic scales is usually micaceous and resembles psoriasis. Most patients are above 50 years of age and are circumcised later in life, but also reported in younger age group. This mica like scales contains keratin which gets dissolved in 10% potassium hydroxide solution. Disease progression may lead to phimosis. Differential diagnosis of this disease entity include moniliasis, wart, psoriasis ,penile horn, circinate balanitis, erythroplasia of Queyrat, squamous cell epithelioma and verrucous carcinoma. It is primarily a benign entity, it is capable of invasiveness. Bart and Kopf considered it to be in intermediate stage between benign hyperplasia and squamous cell carcinoma. However, the histological spectrum can range from hypertrophic-hyperplastic penile dystrophy to verrucous carcinoma. Fibro sarcoma has been reported developing in a same patient. Etiology is unclear. Despite search for a viral agent, Human Papilloma Virus (HPV) has not been demonstrated and its role in pathogenesis or its transformation to verrucous carcinoma has been proved. The treatment of PEKMB should be conservative when there is no histological evidence of malignancy. All such patients should be followed up. Treatment choices include potent topical steroids, topical 5% 5-flurouracil cream1, 2, cryotherapy, radiotherapy and shaving biopsy plus electro coagulation. When frank malignancy is observed, excision with wide margin is the rule.

NCT ID: NCT04709588 Completed - Skin Condition Clinical Trials

Hydrolyzed Collagen Combined With Djulis and Green Caviar Improve Skin Condition

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Collagen combined with djulis and green caviar improve skin condition

NCT ID: NCT04679961 Completed - Skin Diseases Clinical Trials

Deep Learning on 3D Cellular-resolution Tomogram

Start date: December 21, 2020
Phase:
Study type: Observational

Skin biopsy is the main method to diagnose skin tumors, skin inflammation, and pigmented diseases. However, biopsy is an invasive method that can cause wounds and scars. Optical coherent tomography (OCT) technology is a fast, non-invasive, non-radioactive, and label-free imaging method. This technology generates real-time images of living tissue by detecting the variations in the refractive indexes of various components in soft tissues. Recently, there is a breakthrough progress that the newly designed ultrahigh resolution OCT can provide in vivo cellular resolution similar to histopathological sections in the high magnification. In our previous clinical trial "Early feasibility study: application of OCT imaging in dermatology" (approved by IRB of MacKay Memorial Hospital, no. 17CT062Be), it showed characteristic features of different skin inflammatory diseases and tumors can be distinguished successfully in tomograms. There were no adverse event or serious adverse event in this trial. Artificial intelligence technologies have been used widely in the image analysis in recent years. Hence, we aim to collect OCT tomograms of common skin inflammatory diseases, skin tumors, and pigmented diseases, and compare with normal skin for machine learning. We expect the integration of tomograms with deep learning artificial intelligence may assist identifying histological features in these images and provide new alternative way for non-invasive diagnosis in dermatology.

NCT ID: NCT04676763 Completed - Skin Diseases Clinical Trials

Substance P Challenge in Healthy Participants

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

The objectives of this enabling study are to characterize the wheal and flare responses over time following skin challenges with ascending concentrations of Substance P. This will be a 2-part study: Part 1 will aid in the understanding of the wheal and flare responses following Substance P. Part 2 will investigate the variability of the responses. Participants may be enrolled into Part 1 or Part 2, not both.

NCT ID: NCT04586816 Completed - Photoaging Clinical Trials

Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging

Start date: September 10, 2019
Phase: N/A
Study type: Interventional

Recent research has reported that the maple leaf extract exhibits anti-aging effects by inhibiting elastase activity, thereby preventing the breakdown of elastin and interfering with the formation of wrinkles. Red maple leaf extract contains phenolic compounds known as glucitol-core-containing gallotannins (GCGs) which help reduce the appearance of wrinkles and may decrease skin inflammation, dark spots and pigmentation. The objective of this study is to examine the effects of topical Maplifa on the cosmetic appearance of facial lines, redness and skin tone.

NCT ID: NCT04562168 Completed - Skin Diseases Clinical Trials

Using AI as a Diagnostic Decision Support Tool to Help the Diagnosis of Skin Disease in Primary Healthcare in Catalonia

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

Background: Dermatological conditions are a relevant health problem. Machine learning models are increasingly being applied to dermatology as a diagnostic decision support tool using image analysis, specially for skin cancer detection and classification. Objective: The objective of this study is to perform a prospective validation of an image analysis ML model, which is capable of screening 44 different skin disease types, comparing its diagnostic capacity with that of General Practitioners (GPs) and dermatologists. Methods: In this prospective study 100 consecutive patients who visit a participant GP with a skin problem in central Catalonia will be recruited, data collection is planned to last 7 months. Skin diseases anonymized pictures will be taken and introduced in the ML model interface, which will return top 5 accuracy diagnosis. The same image will be also sent as a teledermatology consultation, following the current workflow. GP, ML model and dermatologist/s assessments will be compared to calculate the precision, sensitivity, specificity and accuracy of the ML model.

NCT ID: NCT04541329 Completed - Psoriasis Vulgaris Clinical Trials

Predicting Inflammatory Skin Disease Response to IL-23 Blockade

Start date: September 16, 2020
Phase: Phase 4
Study type: Interventional

This study examines the effect of IL-23 blockade with Tildrakizumab on the immune cells of psoriatic skin lesions.